ALIGN TECHNOLOGY, INC. (ALGN) Gross Margin
- Gross margin · 12 months: Value 68.05%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 68.05% | Gross profit / revenue. Period ending 2026-06-30. $2.82B ÷ $4.14B × 100 ≈ 68.05% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 2.82B USD | Gross Profit |
| Revenue | 4.14B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $2.82B | $4.14B | (m) | 68.05% |
| 2026-03-31 | $2.77B | $4.10B | (m) | 67.57% |
| 2025-12-31 | $2.71B | $4.03B | (m) | 67.19% |
| 2025-09-30 | $2.72B | $3.98B | (m) | 68.41% |
| 2025-06-30 | $2.77B | $3.96B | (m) | 69.79% |
| 2025-03-31 | $2.78B | $3.98B | (m) | 69.87% |
| 2024-12-31 | $2.80B | $4.00B | (m) | 70.00% |
| 2024-09-30 | $2.77B | $3.96B | (m) | 69.98% |
| 2024-06-30 | $2.75B | $3.94B | (m) | 69.82% |
| 2024-03-31 | $2.74B | $3.92B | (m) | 70.06% |
| 2023-12-31 | $2.71B | $3.86B | (m) | 70.08% |
| 2023-09-30 | $2.66B | $3.81B | (m) | 69.74% |
| 2023-06-30 | $2.61B | $3.74B | (m) | 69.87% |
| 2023-03-31 | $2.59B | $3.70B | (m) | 69.78% |
| 2022-12-31 | $2.63B | $3.73B | (m) | 70.52% |
| 2022-09-30 | $2.76B | $3.86B | (m) | 71.44% |
| 2022-06-30 | $2.90B | $3.99B | (m) | 72.60% |
| 2022-03-31 | $2.97B | $4.03B | (m) | 73.62% |
| 2021-12-31 | $2.94B | $3.95B | (m) | 74.26% |
| 2021-09-30 | $2.80B | $3.76B | (m) | 74.58% |
| 2021-06-30 | $2.58B | $3.47B | (m) | 74.27% |
| 2021-03-31 | $2.05B | $2.82B | (m) | 72.66% |
| 2020-12-31 | $1.76B | $2.47B | (m) | 71.33% |
| 2020-09-30 | $1.62B | $2.29B | (m) | 71.04% |
| 2020-06-30 | $1.53B | $2.16B | (m) | 70.74% |
| 2020-03-31 | $1.74B | $2.41B | (m) | 72.08% |
| 2019-12-31 | $1.74B | $2.41B | (m) | 72.46% |
| 2019-09-30 | $1.66B | $2.29B | (m) | 72.24% |
| 2019-06-30 | $1.59B | $2.19B | (m) | 72.60% |
| 2019-03-31 | $1.52B | $2.08B | (m) | 73.25% |
| 2018-12-31 | $1.45B | $1.97B | (m) | 73.63% |
| 2018-09-30 | $1.38B | $1.85B | (m) | 74.59% |
| 2018-06-30 | $1.30B | $1.73B | (m) | 75.18% |
| 2018-03-31 | $1.21B | $1.60B | (m) | 75.55% |
| 2017-12-31 | $1.12B | $1.47B | (m) | 75.81% |
| 2017-09-30 | $1.02B | $1.35B | (m) | 75.77% |
| 2017-06-30 | $935.99M | $1.24B | (m) | 75.57% |
| 2017-03-31 | $870.29M | $1.15B | (m) | 75.58% |
| 2016-12-31 | $815.29M | $1.08B | (m) | 75.50% |
| 2016-09-30 | $767.86M | $1.02B | (m) | 75.51% |
| 2016-06-30 | $716.23M | $945.99M | (m) | 75.71% |
| 2016-03-31 | $669.65M | $886.12M | (m) | 75.57% |
| 2015-12-31 | $640.11M | $845.49M | (m) | 75.71% |
| 2015-09-30 | $617.96M | $813.81M | (m) | 75.93% |
| 2015-06-30 | $605.44M | $796.05M | (m) | 76.06% |
| 2015-03-31 | $592.28M | $779.09M | (m) | 76.02% |
| 2014-12-31 | $578.44M | $761.65M | (m) | 75.95% |
| 2014-09-30 | $564.26M | $741.35M | (m) | 76.11% |
| 2014-06-30 | $544.29M | $715.98M | (m) | 76.02% |
| 2014-03-31 | $522.51M | $687.27M | (m) | 76.03% |
| 2013-12-31 | $498.11M | $660.21M | (m) | 75.45% |
| 2013-09-30 | $468.11M | $624.75M | (m) | 74.93% |
| 2013-06-30 | $443.37M | $596.74M | (m) | 74.30% |
| 2013-03-31 | $428.48M | $578.54M | (m) | 74.06% |
| 2012-12-31 | $416.39M | $560.04M | (m) | 74.35% |
| 2012-09-30 | $405.46M | $546.11M | (m) | 74.25% |
| 2012-06-30 | $397.48M | $535.50M | (m) | 74.23% |
| 2012-03-31 | $379.82M | $509.96M | (m) | 74.48% |
| 2011-12-31 | $361.28M | $479.74M | (m) | 75.31% |
| 2011-09-30 | $337.49M | $443.73M | (m) | 76.06% |
| 2011-06-30 | $320.05M | $413.78M | (m) | 77.35% |
| 2011-03-31 | $315.93M | $401.89M | (m) | 78.61% |
| 2010-12-31 | $303.42M | $387.13M | (m) | 78.38% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $233.49M | $312.33M | (m) | 74.76% |
| 2009-09-30 | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2008-12-31 | $225.13M | $303.98M | (m) | 74.06% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |